Monitoring: Regular assessment of vital signs, laboratory tests, and symptoms to detect early signs of CRS. Medications: Administration of corticosteroids, tocilizumab (an IL-6 receptor antagonist), and other immunosuppressive agents to control excessive cytokine release. Supportive Care: Providing fluids, oxygen, and other supportive measures to manage symptoms and prevent complications. Education: Educating patients and their families about the signs and symptoms of CRS and the importance of timely reporting.
